TY - JOUR
T1 - Pathophysiological characteristics of melanoma in-transit metastasis in a lymphedema mouse model
AU - Oashi, Kohei
AU - Furukawa, Hiroshi
AU - Nishihara, Hiroshi
AU - Ozaki, Michitaka
AU - Oyama, Akihiko
AU - Funayama, Emi
AU - Hayashi, Toshihiko
AU - Kuge, Yuji
AU - Yamamoto, Yuhei
N1 - Funding Information:
This study was funded by a grant-in-aid (10101-05-1-7312-0001) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
PY - 2013/2
Y1 - 2013/2
N2 - In-transit metastasis (ITM) is a unique manifestation of intralymphatic tumor dissemination, characterized by the presence of melanoma cells between the primary lesion and the draining regional lymph node basin that is clinically associated with poor prognosis. In this study, we aimed to establish an experimental animal model of melanoma ITM, as research progress in this field has been hampered by a lack of suitable experimental models. We reproduced melanoma ITM in a mouse hind limb by transplanting melanoma cells into the footpad of a mouse with lymphedema (LE). The tumor cells at the ITM site were highly proliferative, and mice with ITMs were more likely than control mice to develop distant lymph node and lung metastases. Peritumoral lymphatic vessels and tumor-associated blood vessels were increased in the primary tumor site of the LE mice. Our established ITM melanoma mouse model enabled us to clarify the molecular determinants and pathophysiology of ITM. This ITM model is also comparable to the unfavorable clinical behavior of melanoma ITM in humans and, moreover, underlined the importance of lymphangiogenic factors in the tumor dissemination through the lymphatic system.
AB - In-transit metastasis (ITM) is a unique manifestation of intralymphatic tumor dissemination, characterized by the presence of melanoma cells between the primary lesion and the draining regional lymph node basin that is clinically associated with poor prognosis. In this study, we aimed to establish an experimental animal model of melanoma ITM, as research progress in this field has been hampered by a lack of suitable experimental models. We reproduced melanoma ITM in a mouse hind limb by transplanting melanoma cells into the footpad of a mouse with lymphedema (LE). The tumor cells at the ITM site were highly proliferative, and mice with ITMs were more likely than control mice to develop distant lymph node and lung metastases. Peritumoral lymphatic vessels and tumor-associated blood vessels were increased in the primary tumor site of the LE mice. Our established ITM melanoma mouse model enabled us to clarify the molecular determinants and pathophysiology of ITM. This ITM model is also comparable to the unfavorable clinical behavior of melanoma ITM in humans and, moreover, underlined the importance of lymphangiogenic factors in the tumor dissemination through the lymphatic system.
UR - http://www.scopus.com/inward/record.url?scp=84872620812&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872620812&partnerID=8YFLogxK
U2 - 10.1038/jid.2012.274
DO - 10.1038/jid.2012.274
M3 - Article
C2 - 22951727
AN - SCOPUS:84872620812
SN - 0022-202X
VL - 133
SP - 537
EP - 544
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 2
ER -